Skip to main content

Table 3 Multivariate predictors of survival

From: Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery

Variables

Risk ratio

95% CI

P value

Group, the experimental group /control

  

0.925

T stage, T1 ~ 3/T4

15.071

1.809–125.553

0.012

Histological diagnosis, Well and intermediately differentiated/poorly differentiated

  

0.360

Change of tumor markers, Decrease and stable/increase

  

0.167

N stage, N0/N1–3

  

0.122

P stage, 1–2/3

  

0.076